Avidity of the Immunoglobulin G Response to aNeisseria meningitidisGroup C Polysaccharide Conjugate Vaccine as Measured by Inhibition and Chaotropic Enzyme-Linked Immunosorbent Assays
- 1 April 2007
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 14 (4) , 397-403
- https://doi.org/10.1128/cvi.00241-06
Abstract
Antibody avidity, the strength of the multivalent interaction between antibodies and their antigens, is an important characteristic of protective immune responses. We have developed an inhibition enzyme-linked immunosorbent assay (ELISA) to measure antibody avidity for the capsular polysaccharide (PS) ofNeisseria meningitidisgroup C (MnC) and determined the avidity constants (KDs) for 100 sera from children immunized with an MnC PS conjugate vaccine. The avidity constants were compared to the avidity indices (AI) obtained for the same sera using a chaotropic ELISA protocol. After the primary immunization series, the geometric mean (GM)KDwas 674 nM and did not change in the months following immunization. However, the GM avidity did increase after the booster dose (GMKD, 414 nM 1 month after booster immunization). In contrast, the GM AI increased from an initial value of 118 after the primary immunization series to 147 6 months after the completion of the primary immunization series and then further increased to 178 after booster immunization. At the individual subject level, the avidity constant and AI correlated after the primary immunization series and after booster immunization but not prior to boosting. This work suggests that the AI, as measured by the chaotropic ELISA, in contrast to theKD, reflects changes that render antibody populations less susceptible to disruption by chaotropic agents without directly affecting the strength of the binding interactions.Keywords
This publication has 33 references indexed in Scilit:
- Avidity Determinations for Haemophilus influenzae Type b Anti-Polyribosylribitol Phosphate AntibodiesClinical and Vaccine Immunology, 2005
- Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old childrenVaccine, 2005
- Analysis of Human Serum Immunoglobulin G againstO-Acetyl-Positive andO-Acetyl-Negative Serogroup W135 Meningococcal Capsular PolysaccharideClinical and Vaccine Immunology, 2005
- Kinetics and Avidity of Antibodies Evoked by Heptavalent Pneumococcal Conjugate Vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine TrialInfection and Immunity, 2005
- Effects of Prior Polysaccharide Vaccination on Magnitude, Duration, and Quality of Immune Responses to and Safety Profile of a Meningococcal Serogroup C Tetanus Toxoid Conjugate Vaccination in AdultsClinical and Vaccine Immunology, 2004
- Effect of Antigen Coating Conditions on Enzyme-Linked Immunosorbent Assay for Detection of Immunoglobulin G Antibody to Neisseria meningitidis Serogroup Y and W135 Capsular Polysaccharide Antigens in SerumClinical and Vaccine Immunology, 2003
- Age-Related Disparity in Functional Activities of Human Group C Serum Anticapsular Antibodies Elicited by Meningococcal Polysaccharide VaccineInfection and Immunity, 2003
- Antibody Persistence and Immunological Memory at Age 4 Years after Meningococcal Group C Conjugate Vaccination in Children in the United KingdomThe Journal of Infectious Diseases, 2002
- Avidity Maturation of Antibody toHaemophilus influenzaeType b (Hib) after Immunization with Diphtheria‐Tetanus–Acellular Pertussis–Hib–Hepatitis B Combined Vaccine in InfantsThe Journal of Infectious Diseases, 1999
- Evidence for the Extended Helical Nature of Polysaccharide Epitopes. The 2.8 .ANG. Resolution Structure and Thermodynamics of Ligand Binding of an Antigen Binding Fragment Specific for .alpha.-(2.fwdarw.8)-Poly(sialic acid)Biochemistry, 1995